Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-010102
Filing Date
2023-03-03
Accepted
2023-03-03 17:16:12
Documents
1
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5603
  Complete submission text file 0001140361-23-010102.txt   7027
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ATARA BIOTHERAPEUTICS, INC. 611 GATEWAY BOULEVARD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address
Touchon Pascal (Reporting) CIK: 0001780060 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36548 | Film No.: 23705780